Tandem Diabetes Care (TNDM) Amortizatization of Intangibles (2020 - 2021)
Tandem Diabetes Care's (TNDM) quarterly Amortizatization of Intangibles came in at -$223000.0 in Q3 2021, down 169.91% on a YoY basis from $319000.0 in Q3 2020, and down 169.91% quarter-over-quarter from $319000.0 in Q3 2020.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Amortizatization of Intangibles for 2 consecutive years, with -$223000.0 the latest figure, recorded in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | - |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | - |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -223,000.00 |
| Sep 30, 2020 | 319,000.00 |